Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia

There is conflicting information about the influence of body mass index (BMI) on the pharmacokinetics, toxicity, and outcome of chemotherapy. We compared pharmacokinetics, outcome, and toxicity data across 4 BMI groups (underweight, BMI ≤ 10th percentile; normal; at risk of overweight, BMI ≥ 85th an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hijiya, Nobuko, Panetta, John C., Zhou, Yinmei, Kyzer, Emily P., Howard, Scott C., Jeha, Sima, Razzouk, Bassem I., Ribeiro, Raul C., Rubnitz, Jeffrey E., Hudson, Melissa M., Sandlund, John T., Pui, Ching-Hon, Relling, Mary V.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Hematology 2006
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895448/
https://ncbi.nlm.nih.gov/pubmed/16917005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-05-024414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados